Home » Stocks » PBIO

Pressure BioSciences Inc. (PBIO)

Stock Price: $2.00 USD -0.09 (-4.31%)
Updated May 7, 2021 3:30 PM EDT - Market closed
Market Cap 9.03M
Revenue (ttm) 1.22M
Net Income (ttm) -17.58M
Shares Out 4.32M
EPS (ttm) -5.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $2.00
Previous Close $2.09
Change ($) -0.09
Change (%) -4.31%
Day's Open 2.01
Day's Range 1.89 - 2.01
Day's Volume 17,465
52-Week Range 1.30 - 3.95

News

Hide News

Conference Call Scheduled for Wednesday, April 21st at 4:30pm ET SOUTH EASTON, MA / ACCESSWIRE / April 19, 2021 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that ...

2 weeks ago - Accesswire

Company Expects Acquisition to be Accretive with Sustained Profitable Revenue Growth, Leveraging Market-Changing Synergy from PBI's Ultra Shear Technology Nanoemulsions Platform SOUTH EASTON, MA / ACCES...

3 weeks ago - Accesswire

About PBIO

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the Americas, Europe, Asia, Africa, and Australia. Its pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. It als... [Read more...]

Industry
Medical Devices
IPO Date
Oct 31, 1996
Stock Exchange
OTCMKTS
Ticker Symbol
PBIO
Full Company Profile

Financial Performance

In 2020, PBIO's revenue was $1.22 million, a decrease of -32.56% compared to the previous year's $1.81 million. Losses were -$16.01 million, 37.3% more than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for PBIO is 1.57, which is a decrease of -21.50% from the latest price.

Price Target
$1.57
(-21.50% downside)